retatrutide for women side effects Guide: 21 Proven Remedies That Work Fake Retatrutide is spreading online

Retatrutide is a next-generation triple receptor agonist that simultaneously activates GLP-1, GIP, and glucagon receptors, making it one of the most studied compounds in modern metabolic peptide research

Box 1: Recent Trump Administration Obesity Drug Initiatives In November 2025, the Trump administration announced reaching a deal with Eli Lilly and Novo Nordisk to lower the cost of their GLP-1s for Medicare, Medicaid, and those purchasing the drugs directly from the manufacturers through a new TrumpRx website

In addition, evaluation and management of various nonhepatic complications of obesity and MAFLD is also important

Retatrutide is being studied because researchers are evaluating whether adding glucagon receptor activity may further influence energy expenditure and weight reduction